Drug CROs: Good Medicine for Investors

According to The Motley Fool, CROs are a solid investment for investors because they have experienced substantial growth because of increased research and development outsourcing by the biopharmaceutical industry. They outline specific CROs to watch in the coming years. What do you think? In a tough economic environment--are CROs solid for investment?

CROs Under Fire

This article on Bio Health Investor discusses how although CROs experienced rapid growth up until August this year, it seems as if the trend is coming to a crashing halt. Apparently CROs are not immune to the global economic crisis; Charles River Laboratories have even reported that it is cutting its guidance for 2008.

Now there is even a concern for the amount of jobs that will be available in the CRO sector. CRO stocks have been performing horrible as of lately. Time will only tell what the future lies in store for the medical industry.

Economic Crisis Presents an Opportunity for the Indian Pharma Outsourced Industry

This latest article on BioPharmaLife discusses how even though clinical trials in the US are going through a rough patch the Indian pharma outsourced industry is expected to thrive due to the economic crisis.

With many companies pulling back on investments, drug-makers are turning to India for cheaper resources for manufacturing and research. By the year 2011, the US is expected to have outsourced 65% of all its clinical trials to India.